Retinal melanoma is a rare eye cancer that can affect vision and, in some cases, spread to other parts of the body. Early symptoms of retinal melanoma may include blurred vision, flashes, floaters, or a dark spot in the eye, but some people have no symptoms at first. It usually affects adults, especially in middle age or later life, and it often needs long-term follow-up after treatment. Not everyone will have the same experience. Treatment for retinal melanoma often includes targeted radiation, laser treatment, or surgery, and survival depends partly on the tumor size, location, and whether the cancer has spread.
How many people live with Retinal melanoma?
Reliable separate counts for retinal melanoma are not usually published worldwide or in the United States. Major cancer tracking sources such as GLOBOCAN and SEER generally group it with other eye melanomas, so there is no trustworthy stand-alone estimate of how many people are living with retinal melanoma specifically.
Overview
Retinal melanomaSymptoms
Retinal melanoma often causes no symptoms at first. When symptoms appear, people with retinal melanoma may notice blurred vision, flashes, floaters, a dark spot in vision, or gradual loss of side vision.
Outlook and prognosis
Outlook for retinal melanoma often depends on tumor size, location, and whether it has spread beyond the eye. Many people do well after treatment, but some have lasting vision changes and need long-term scans and eye checks.
Causes and risk factors
Retinal melanoma has no single clear cause. Risk is higher with older age, light-colored eyes or fair skin, certain inherited gene changes, and some unusual eye pigment conditions. Family history can raise risk, while lifestyle links are not well established.
Genetic influences
Genetics matter in retinal melanoma, but most cases are not inherited. Many happen because gene changes develop in the tumor itself, while a small number are linked to inherited changes that can raise risk and guide family testing.
Diagnosis
Retinal melanoma is diagnosed with a dilated eye exam and imaging tests such as ultrasound and retinal scans. If the diagnosis of retinal melanoma is uncertain, doctors may use fluorescein angiography or rarely a biopsy.
Treatment and drugs
Retinal melanoma is usually treated with focused radiation, laser treatment, or surgery to remove the tumor and protect as much vision as possible. Some people also need medicines such as immunotherapy if the cancer has spread.
Symptoms
Retinal melanoma can be easy to miss at first because many people feel well and notice only mild vision changes, if any. When symptoms do happen, they often involve blurry sight, flashes, floaters, or a dark area off to one side. Symptoms vary from person to person and can change over time. The early symptoms of retinal melanoma often depend on where the growth sits inside the eye and how large it is.
Early retinal melanoma often causes no obvious symptoms, so many people do not notice a problem right away. It may first be found during a routine dilated eye exam.
Vision may become fuzzy or less sharp, sometimes in just one eye. Reading, driving, or seeing details across a room can start to feel harder than usual.
Some people with retinal melanoma notice brief flashes of light or drifting specks, dots, or cobweb-like shapes. These changes can happen when the inside of the eye is being irritated or the retina is affected.
A dark spot, missing area, or curtain-like shadow can appear in part of the visual field. This may show up as missing words while reading or not noticing objects on one side.
How people usually first notice Retinal melanoma?
People usually first notice retinal melanoma when vision changes seem to come out of nowhere: blurry vision, flashes of light, new floaters, or a dark spot in part of what they see. Some people have no symptoms at first, and the tumor is found during a routine eye exam when an eye doctor sees a new pigmented growth or fluid under the retina. Because these early warning signs can also happen with less serious eye problems, any sudden or unexplained change in vision deserves prompt medical attention.
Types of Retinal melanoma
When people say retinal melanoma, they often mean melanoma that develops inside the eye. In practice, doctors usually sort these tumors by where they start, because that often affects how they behave and what changes people notice day to day. Symptoms don’t always look the same for everyone. For many, the early symptoms of retinal melanoma may be subtle, and some people have no symptoms until an eye exam picks it up.
Iris melanoma
This type starts in the colored part at the front of the eye and is often found earlier because it can be seen during a routine exam or in the mirror. Many living with this form notice a dark spot that seems to grow, a change in pupil shape, or blurred vision. It often grows more slowly than other types of retinal melanoma inside the eye.
Ciliary body melanoma
This type begins in a ring-shaped structure just behind the iris, so it can stay hidden for longer. Some may find their vision gets blurry, their glasses seem less helpful, or they notice pressure, discomfort, or a change in the lens position. Because it is harder to see, it may be larger by the time it is diagnosed.
Choroidal melanoma
This is the most common intraocular type and starts in the layer beneath the retina at the back of the eye. People with choroidal melanoma may notice blurred vision, flashes, floaters, or a shadow in part of their sight, although some have no symptoms at first. Among the main types of retinal melanoma, this one is most often found on a dilated eye exam or eye scan.
Can I slow down the onset of symptoms?
Probably not: there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of retinal melanoma, a rare eye cancer, and healthy habits have not been shown to prevent it. What is well established is early eye care, because regular dilated eye exams, especially for people with unusual eye spots or a family history, may catch it before it causes symptoms, but that is early detection, not prevention. Research is still looking at why this cancer starts, so while you may not be able to slow its onset, getting eye changes checked promptly can still make a real difference.
What genetics can tell you about symptoms
Genetics can offer some clues, but for retinal melanoma, symptoms often depend more on where the tumor is in the eye and how large it is than on a person’s inherited genes. Changes in certain tumor genes can be linked to how the cancer behaves, including how aggressive it may be, but they do not reliably predict exactly which vision symptoms will show up, how severe they will feel, or when they will start. For many people, blurred vision, flashes, floaters, or a shadow in part of the visual field are shaped mainly by the tumor’s position inside the eye rather than by genetics alone.
Causes and risk factors
When retinal melanoma is found, many people want to know why it happened. The exact causes of retinal melanoma are often unclear, but it begins when pigment-making cells inside the eye start growing out of control. Risk is higher with older age, light-colored eyes, fair skin, and certain dark spots in or around the eye. Rare inherited gene changes, including BAP1, and a family history of eye melanoma can also raise risk. Unlike skin melanoma, lifestyle and environmental links are weaker, and having risk factors doesn’t mean you’ll definitely develop the condition.
What are the most common causes or risk factors?
For most people, the exact cause of retinal melanoma is not clear, but it is seen more often in older adults, especially those with lighter skin and blue or green eyes. Risk can also be higher in people born with extra pigment in or around the eye, and in families with inherited gene changes that raise the chance of melanoma or other cancers. Unlike skin melanoma, sunlight has not been clearly proven to be a major cause of this type of eye melanoma.
Environmental and biological risk factors
Understanding the main risk factors for retinal melanoma can help explain why doctors watch some eye changes more closely. Doctors often group risks into internal (biological) and external (environmental). For retinal melanoma, the strongest known risks are mostly biological, and having one of them does not mean you will get this cancer.
Retinal melanoma is diagnosed more often in older adults, especially from middle age onward. Risk rises over time as pigment cells in the eye have had more years to collect harmful changes.
People with light-colored eyes, especially blue or green, have a higher risk than those with darker eyes. Fair skin often appears in the same pattern, although these traits do not mean cancer is likely.
People born with extra pigment in or around the eye have a clearly higher risk. This can include dark patches on the white of the eye or deeper pigment changes that an eye doctor sees during an exam.
A mole or freckle inside the eye, often called an eye nevus, is a known risk factor for retinal melanoma. Most of these spots never become cancer, but they may need regular follow-up to check for change.
Genetic risk factors
Most cases of retinal melanoma are linked to gene changes that arise in the eye tumor itself rather than changes passed down in families. When people ask about the genetic risk factors for retinal melanoma, the main ones are rare inherited gene changes, family history, and certain inherited pigment traits. Some risk factors are inherited through our genes. The best-known inherited cause is a BAP1 gene change, but inherited causes are still uncommon overall.
GNAQ or GNA11: Many retinal melanoma tumors have a change in GNAQ or GNA11. These changes usually develop only in the tumor cells during life, so they are not usually inherited from a parent.
PLCB4 or CYSLTR2: A smaller number of tumors start with changes in PLCB4 or CYSLTR2 instead. Like GNAQ and GNA11 changes, these are usually acquired in the eye and not passed through families.
BAP1 changes: An inherited change in BAP1 can greatly raise the risk of retinal melanoma and some other cancers. This is uncommon, but it matters most when several relatives have melanoma, mesothelioma, or kidney cancer. In that setting, genetic counseling and testing may be worth discussing.
Family history: Retinal melanoma rarely runs in families, but a close family history of eye melanoma can suggest an inherited predisposition. The chance is still low for most relatives, yet doctors may look more closely at the family pattern if related cancers cluster together.
Light pigmentation: People born with light-colored eyes, fair skin, or easy freckling may have a higher risk of retinal melanoma. These inherited pigment traits can affect how pigment-making cells behave, but most people with them never develop cancer.
Lifestyle risk factors
Lifestyle risk factors for retinal melanoma are not as clearly defined as they are for many other cancers, and most known risks are not related to personal habits. Still, some behaviors may influence overall cancer risk, immune health, treatment tolerance, and recovery. When asking how lifestyle affects retinal melanoma, it is most accurate to say that lifestyle is more likely to shape general health and outcomes than to be a proven direct cause.
Smoking is not a firmly established direct cause of retinal melanoma, but it can increase oxidative stress and promote chronic inflammation. These effects may weaken overall eye and vascular health and can complicate cancer treatment and recovery.
Heavy alcohol use has not been proven to directly cause retinal melanoma, but it can impair liver function and general health. This matters because monitoring for spread to the liver is important in ocular melanoma, so good liver health supports care.
Obesity is not a confirmed direct cause of retinal melanoma, but it is linked to inflammation, insulin resistance, and poorer overall cancer outcomes in many settings. Carrying excess weight may also reduce fitness for surgery, systemic treatment, or recovery.
Lack of regular exercise is not known to specifically trigger retinal melanoma, but it can worsen cardiovascular fitness, fatigue, and metabolic health. Staying active may help preserve strength, treatment tolerance, and quality of life during and after care.
Risk prevention
There is no certain way to prevent retinal melanoma, and many people who develop it have no clear risk factor they could have changed. Prevention is mainly about lowering avoidable risks where possible and finding eye changes early, when treatment may be simpler. Prevention is about lowering risk, not eliminating it completely.
Regular dilated eye exams can sometimes spot retinal melanoma before it causes major vision problems. This matters because early signs of retinal melanoma may be found during an exam even when day-to-day vision still seems normal.
Wearing UV-blocking sunglasses and avoiding unnecessary intense sun exposure may help protect overall eye health. While the link between sunlight and retinal melanoma is not fully clear, reducing UV exposure is a sensible low-risk step.
Tanning beds expose the body to intense ultraviolet light, which can raise melanoma risk in general. Skipping them is a practical way to reduce avoidable exposure, especially if you already have other risk factors.
Some people have a higher chance of retinal melanoma because of fair skin, light-colored eyes, certain inherited conditions, or unusual eye pigmentation. Knowing your personal and family history can help your eye doctor decide how closely to monitor you.
Can you prevent Retinal melanoma?
There is no proven way to fully prevent retinal melanoma, a rare type of eye cancer, because it often develops for reasons you cannot control. Wearing UV-blocking sunglasses in strong sunlight is a sensible step for overall eye health, but it has not been clearly shown to prevent this cancer.
Transmission
Retinal melanoma is not contagious, so you cannot catch it from someone else through touch, coughing, kissing, or sharing items. For most people, it develops because cells in the eye pick up changes over time, not because the cancer was directly passed down in a family.
When people ask about the genetic transmission of retinal melanoma, the key point is that inherited risk is uncommon but possible. A small number of cases are linked to inherited gene changes that raise the risk of melanoma, so if retinal melanoma or several related cancers run in your family, your care team may suggest genetic counseling.
When to test your genes
Gene testing is not used to screen most people for retinal melanoma. It is usually considered if you have a strong family history of uveal or cutaneous melanoma, mesothelioma, or kidney cancer, or if tumor testing after diagnosis could guide follow-up and metastatic risk.
Diagnosis
Retinal melanoma is usually found after changes in vision or during a routine eye exam, rather than from a blood test alone. The diagnosis of retinal melanoma often starts with a close look inside the eye and is then confirmed with specialized eye imaging. It’s natural to worry when symptoms don’t have a clear explanation.
An eye specialist widens the pupil with drops to look carefully at the back of the eye. They check the size, shape, color, and position of the growth and look for warning signs such as fluid, bleeding, or retinal detachment.
Ultrasound uses sound waves to show the tumor’s size, thickness, and internal pattern. This can help confirm whether a suspicious spot is more likely to be melanoma than a harmless mole or another eye condition.
Photos and scans of the back of the eye help document the lesion and track any change over time. Tests such as optical coherence tomography and sometimes dye-based imaging can show fluid, leakage, or effects on nearby retinal tissue.
Doctors usually begin by asking about vision changes, flashes, floaters, blind spots, or eye discomfort. A detailed family and health history can help rule out other causes and guide the next tests.
How is Retinal melanoma diagnosed?
Retinal melanoma is usually diagnosed with a detailed eye exam after drops are used to widen the pupil, along with eye scans such as ultrasound and other special pictures that show the size, shape, and exact place of the growth. Doctors often can tell from the way it looks and whether it has changed over time, so surgery or a tissue sample is not always needed, but a small sample may be taken if the diagnosis is unclear. Genetic testing may sometimes be done on tumor cells to help estimate the risk of the cancer spreading, but it is usually not the main way the diagnosis is made.
Stages of Retinal melanoma
Retinal melanoma is usually grouped into stages based on the size of the tumor and whether it has spread, rather than on a fixed day-to-day pattern of symptoms. In many living with retinal melanoma, the stage is worked out with an eye exam, eye imaging, and scans to check for spread. The early symptoms of retinal melanoma can be subtle, so some tumors are found during a routine eye visit. Step by step, they look for the most likely explanations.
Stage 1
The tumor is small and limited to the eye. Vision may still seem normal, or there may be only mild changes such as blurred vision or floaters.
Stage 2
The retinal melanoma is larger but still has not spread beyond the eye. As it grows, it can be more likely to affect vision or cause pressure-related symptoms.
Stage 3
The cancer is more advanced in or around the eye and may have grown into nearby tissues. Some may find that eye discomfort, more noticeable vision loss, or visible changes become harder to ignore.
Stage 4
The retinal melanoma has spread to distant parts of the body, most often the liver. At this stage, symptoms may come not only from the eye but also from the area where the cancer has spread.
Outlook and prognosis
The outlook for retinal melanoma varies mainly with tumor size, location, genetic features, and whether the cancer has spread beyond the eye. Many people with disease confined to the eye can be treated successfully with radiation, laser-based therapy, or surgery, and local tumor control rates are generally high. Vision prognosis is more variable, because treatment and the tumor itself can damage the retina or optic nerve, leading to partial or severe vision loss in the affected eye. The most important factor for survival is metastatic risk, especially spread to the liver; tumors with high-risk chromosome or gene-expression changes have a substantially worse prognosis than low-risk tumors. If metastasis does not occur, long-term survival can be good, but once metastatic melanoma develops, the prognosis becomes poor and median survival is often measured in months to a few years despite newer systemic treatments. Lifelong follow-up is important because metastases can appear years after the original eye tumor is treated.
Long-term effects
Retinal melanoma can have long-term effects on both vision and overall health, even after treatment ends. For many, this can mean ongoing eye changes, regular scans, and uncertainty about whether the cancer could return or spread. Thinking about the long-term effects helps explain why follow-up care often continues for years. The outlook varies with the size and location of the tumor, whether vision was affected early, and whether the melanoma stays limited to the eye.
Retinal melanoma can leave lasting blind spots, blurred sight, or reduced detail vision in the affected eye. Some people also lose depth perception, which can make driving, reading, or pouring a drink feel less automatic.
Radiation, laser treatment, or surgery can lead to dry eye, cataracts, retinal damage, or rising eye pressure over time. In some cases, the eye becomes painful or loses useful vision, and a small number of people need removal of the eye.
The most serious long-term concern is that retinal melanoma can spread to other parts of the body, especially the liver. This risk may remain for years, which is why doctors often describe these as long-term effects or chronic outcomes.
Many living with retinal melanoma need long-term blood tests, liver imaging, and eye exams to watch for recurrence or spread. Even if early symptoms of retinal melanoma have settled, follow-up usually does not stop quickly.
How is it to live with Retinal melanoma?
Living with retinal melanoma can feel unsettling because daily life often shifts around eye appointments, scans, treatment decisions, and the uncertainty of whether vision will change. Many people with this cancer notice blurred vision, flashing lights, shadows, or blind spots, while others may feel physically well but carry a heavy emotional load as they adapt to the possibility of reduced sight or, in some cases, loss of the eye. For family and close friends, the impact is often practical and emotional at the same time, with loved ones helping with transportation, medical visits, and reassurance while everyone adjusts to worries about treatment and long-term follow-up.
Treatment and drugs
Retinal melanoma is treated based on where the tumor sits in the eye, how large it is, and whether it has spread, so the main goal is to control the cancer while saving as much vision as possible. Small tumors may be watched closely for change, but many people with retinal melanoma are treated with focused radiation, laser-based treatment, or surgery to remove the tumor or, in some cases, the eye if the cancer is large or painful. Treatment often looks different for each person, and for many this can mean balancing the best chance of cancer control with the effect on sight in daily life, such as reading, driving, or recognizing faces. If retinal melanoma has spread outside the eye, care may also include medicines used throughout the body, including immunotherapy or targeted drugs, along with regular scans and blood tests. Supportive care can make a real difference in how you feel day to day, and your eye cancer team can also help with managing treatment side effects and vision changes.
Can you cure Retinal melanoma?
Retinal melanoma can sometimes be cured if it is found early and treated before it spreads, but there is no guaranteed cure for everyone. Treatment may include focused radiation, laser treatment, or surgery to remove or destroy the cancer, and these can often control the tumor and lower the chance of it spreading. If the cancer has already spread to other parts of the body, treatment usually aims to slow it down and help people live longer with fewer symptoms rather than cure it.
Non-drug treatment
Treatment for retinal melanoma often centers on procedures rather than medicines, with the goal of controlling the tumor, protecting vision when possible, and lowering the chance of spread. The best plan depends on the tumor size, where it sits in the eye, and whether vision is already affected. Managing this condition often means balancing eye-preserving care with treatments that more fully remove the cancer. Many people also need follow-up support for vision changes, emotional strain, and long-term monitoring.
Focused radiation is one of the most common treatments for retinal melanoma, especially when doctors hope to save the eye. It can be placed close to the tumor with a small temporary implant or delivered from outside the body. Vision may still change over time, so regular eye checks remain important.
Surgery may remove just the tumor in selected cases, but sometimes the whole eye needs to be removed if the melanoma is large or very painful. This can feel overwhelming, especially if everyday tasks like driving or reading are already harder. If the eye is removed, an artificial eye can usually restore appearance well.
Laser-based treatment may be used for some small tumors or combined with radiation to target the melanoma more directly. This can sometimes help limit damage to nearby tissue, though it is not right for every tumor. Not every approach works the same way for each tumor location.
Some very small suspicious spots are watched closely before treatment, because not every pigmented eye lesion is clearly cancer at first. Follow-up visits usually include detailed eye exams, scans, and photographs to look for growth. This careful monitoring can also help catch early symptoms of retinal melanoma if they begin to appear.
Your genes may have an impact on how drugs work for you
For people with retinal melanoma, genetic testing is used more often to learn how the cancer may behave than to predict how standard medicines will work. If the cancer has spread and drug treatment is needed, changes in the tumor itself can sometimes help doctors judge whether certain newer cancer medicines are more likely to help, and inherited differences in your body may also affect side effects or how strongly medicines for pain or nausea work. Even so, using gene results to choose medicines is not yet a routine part of care for most people living with retinal melanoma.
Pharmacological treatments
For many living with retinal melanoma, medicine is most often used when the cancer cannot be fully removed with local treatment or has spread beyond the eye. The main drug options are newer immune-based treatments, while standard chemotherapy has a smaller role than it does in some other cancers. Not everyone responds to the same medication in the same way. In practice, the best drug treatment for metastatic retinal melanoma depends on the tumor stage, where it has spread, and whether a specific immune marker called HLA-A*02:01 is present.
Tebentafusp is the main targeted immune treatment for some people with advanced retinal melanoma, especially when testing shows HLA-A*02:01. It helps the immune system recognize and attack melanoma cells. It is given by infusion and can cause fever, rash, low blood pressure, or other immune-related reactions that need close monitoring.
Nivolumab and ipilimumab are immunotherapy drugs that remove some of the brakes on the immune system so it can fight cancer more strongly. They may be used together or sometimes one is used alone when retinal melanoma has spread. Side effects can involve inflammation in the gut, liver, lungs, skin, or hormone glands, so regular follow-up is important.
Pembrolizumab is another immunotherapy drug sometimes used for advanced retinal melanoma, usually when doctors are choosing a single immune checkpoint blocker. It may help some people, although response rates are often lower than in skin melanoma. Fatigue, rash, diarrhea, and thyroid problems are among the better-known side effects.
Temozolomide and dacarbazine are chemotherapy drugs that may be considered when immunotherapy is not suitable or has not worked. These medicines have generally shown modest benefit in retinal melanoma compared with newer treatments. Common side effects include nausea, tiredness, and low blood counts, which can raise the risk of infection.
Genetic influences
When retinal melanoma appears, many people first wonder whether it came from their family. In most cases, retinal melanoma is not strongly inherited; the gene changes linked to the tumor usually happen during life in the eye cells themselves rather than being passed down from a parent. A change in a gene can sometimes affect health, and in this cancer, doctors may look for changes in genes such as BAP1 because they can help explain why the tumor developed and how it may behave.
A small number of people with retinal melanoma do have an inherited tendency, especially if they or close relatives have had eye melanoma, mesothelioma, kidney cancer, or several unusual cancers at younger ages. For many living with retinal melanoma, this can mean that genetic counseling or genetic testing for retinal melanoma is worth discussing, particularly when the family history stands out. These tests do not diagnose the tumor by themselves, but they can help guide screening for relatives and give doctors useful information about follow-up and treatment planning.
Is Retinal melanoma genetic?
Genetics matter in retinal melanoma, but most cases are not inherited. Many happen because gene changes develop in the tumor itself, while a small number are linked to inherited changes that can raise risk and guide family testing.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, having a variant connected with a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-understood variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with retinal melanoma, treatment decisions are shaped not just by where the tumor sits in the eye, but also by its genetic makeup. Testing the tumor can show gene changes that help doctors estimate how likely the cancer is to spread, which can affect how closely you are monitored and whether newer treatments or clinical trials are considered. In advanced retinal melanoma, one medicine called tebentafusp is only an option for people who have a specific inherited immune-system marker found on a blood test, so genetics can directly affect which drug you can receive. Other medicines, including immunotherapy and targeted drugs, may work better in some tumor subtypes than others, although treatment responses in retinal melanoma are often more limited than in skin melanoma. Genetics is only one factor, because the tumor’s size, its exact location, whether it has spread, and your overall health also help shape the plan. If you are discussing genetic testing for retinal melanoma treatment, ask whether the test is looking at the tumor, your inherited DNA, or both, since those results can guide different parts of care.
Interactions with other conditions
Changes in vision from retinal melanoma can sometimes be mistaken for more common eye problems, such as retinal detachment, bleeding inside the eye, or age-related eye disease, which can delay diagnosis. Another important aspect is how it may link with other diseases. In some people, retinal melanoma is part of a wider cancer tendency in the family, especially when there is an inherited change such as BAP1 tumor predisposition, so doctors may ask about relatives with melanoma, kidney cancer, or mesothelioma. Many living with retinal melanoma also need careful follow-up for spread outside the eye, most often to the liver, because this can affect symptoms, treatment choices, and overall health. If someone already has another serious illness, such as liver disease or an immune condition, treatment planning may be more complex and usually involves several specialists. Because the early symptoms of retinal melanoma can overlap with other eye conditions, prompt assessment by an eye cancer specialist is important when new flashes, floaters, blurred vision, or a shadow in the field of view appear.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Retinal melanoma?
Retinal detachment, bleeding inside the eye, and age-related damage to the center of vision can all cause blurry vision, flashes, floaters, or a dark area in part of your sight, so they may seem similar at first. A harmless dark spot inside the eye, often called an eye freckle or mole, can also look like retinal melanoma during an eye exam.
History
Long before modern eye scans, doctors had to rely on what they could see through the pupil and what happened to vision over time. Someone might notice a dark shadow in one eye, blurred sight while reading, or flashes and floaters that do not go away. In older medical writing, tumors inside the eye were often hard to sort out, and the term retinal melanoma was sometimes used more loosely than it is today.
As medical science evolved, doctors became better at telling one eye tumor from another. A major step came in the 1800s, when improved examination tools let physicians look into the eye more directly and describe pigmented growths with much greater detail. Over time, many cases once labeled retinal melanoma were reclassified more precisely, because doctors learned that melanomas inside the eye usually arise from pigment-producing cells in nearby structures rather than the light-sensing retina itself.
By the late 19th and early 20th centuries, pathologists studying tissue under the microscope added another layer of understanding. This helped separate melanoma from other causes of vision loss or a visible mass in the eye, such as bleeding, inflammation, or different kinds of cancer. For many living with retinal melanoma, this change in classification mattered because it improved diagnosis, helped guide treatment, and made it easier for doctors to compare outcomes from one patient to another.
In the second half of the 20th century, ultrasound and other imaging methods made it possible to study these tumors without removing the eye in many cases. Later, more focused treatments, including radiation aimed at preserving vision when possible, began to replace older approaches that often required removal of the eye. Researchers also learned that some intraocular melanomas have a genetic basis, although the details belong in a separate discussion of causes.
Today, when people hear retinal melanoma, doctors may clarify the exact type and location of the tumor because naming has become much more precise. Knowing this history helps explain why older reports can sound different from modern ones, and why the same condition may have been described in several ways over time.